GLP-1 agonists are currently used at doses that are too high, but low-dose microdosing could be a useful tool to help people change dietary habits.

“My concern is that the dose of GLP1 that we're using now, it's just a little too much of a good thing.”

Weight loss medications can be a helpful tool to regulate appetite and prevent the obsession with food, though they may have side effects.

“and what it really does is it makes you stop prioritizing food for everything because it [ __ ] with your appetite”

GLP-1 drugs are a capitalistic instrument that profit from recurring chronic disease treatment rather than promoting effective long-term health solutions.

“GLP-1 is an absolute disaster, and it is a capitalistic instrument for the pharma companies to leverage the insecurity of Indians to make millions of dollars.”

Dr. Tiller suggests that while weight loss drugs like semaglutide show effectiveness in trials, there is a lack of long-term data regarding their safety over many years of use.

“one caveat to that is we don't have studies on people that have been taking this drug for five or ten years so we don't know what the very long long term effects might be”